Which has the lower trailing P/E, CHE or OSCR?

OSCR has the lower trailing P/E: CHE trades at 26.12 and OSCR at 22.31. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or OSCR?

Over the past five years, OSCR grew revenue faster — CHE at a 4.12% CAGR versus OSCR at 64.83%.

Does CHE or OSCR pay a bigger dividend?

CHE pays a dividend (0.48% yield), while OSCR has no payments in the available dividend history.

Is CHE or OSCR more profitable?

CHE runs the higher net margin — CHE at 10.60% versus OSCR at 3.60%.

How have CHE and OSCR total returns compared?

Over the past 5 years, CHE delivered 15.15% and OSCR delivered 18.01% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Chemed Corporation and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.80B

$520.27HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

OSCR

Oscar Health, Inc.

$7.79B

$30.05HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — CHE vs OSCR

growth of $100 · dividends reinvested · last 5y

CHE +29.4% (+5.3%/yr)OSCR -10.2% (-2.1%/yr)CHE compounded faster over this window

CHE OSCR

CHE vs OSCR: by the numbers

•OSCR is the larger company ($7.79B vs $6.80B market cap).
•OSCR trades at the lower trailing earnings multiple (22.31 vs 26.12 P/E), one valuation lens rather than an overall verdict.
•CHE converts more revenue to profit (10.60% vs 3.60% net margin).
•OSCR grew revenue faster over the past five years (64.83% vs 4.12% CAGR).
•CHE pays a dividend (0.48% yield), while OSCR has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	OSCR
P/E ratio	26.12	22.31
Forward P/E	20.38	18.12
P/S ratio	2.69	0.68
P/B ratio	8.41	5.08
EV / EBITDA	17.50	10.38
FCF yield	4.63%	41.67%

Profitability

Metric	CHE	OSCR
Gross margin	30.44%	14.38%
Operating margin	13.46%	4.07%
Net margin	10.60%	3.60%
ROE	33.11%	26.84%
ROIC	19.48%	22.98%

Dividends

Metric	CHE	OSCR
Dividend yield	0.48%	N/A
Payout ratio	13.57%	N/A

Growth (annualized)

Metric	CHE	OSCR
Revenue CAGR (5Y)	4.12%	64.83%
EPS CAGR (5Y)	-1.65%	N/A
FCF CAGR (5Y)	-5.44%	80.81%
Total return CAGR (5Y)	2.27%	18.01%

Frequently asked

Which has the lower trailing P/E, CHE or OSCR?: OSCR has the lower trailing P/E: CHE trades at 26.12 and OSCR at 22.31. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or OSCR?: Over the past five years, OSCR grew revenue faster — CHE at a 4.12% CAGR versus OSCR at 64.83%.
Does CHE or OSCR pay a bigger dividend?: CHE pays a dividend (0.48% yield), while OSCR has no payments in the available dividend history.
Is CHE or OSCR more profitable?: CHE runs the higher net margin — CHE at 10.60% versus OSCR at 3.60%.
How have CHE and OSCR total returns compared?: Over the past 5 years, CHE delivered 15.15% and OSCR delivered 18.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full OSCR analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Oscar Health P/E ratio Chemed dividend yield Chemed ROE Oscar Health ROE Chemed operating margin Oscar Health operating margin Chemed revenue growth Oscar Health revenue growth Chemed free cash flow Oscar Health free cash flow

Chemed & Oscar Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.